MetLife FY 2025 premiums rise 10% to USD 49.78B

Reuters
02/20
MetLife FY 2025 premiums rise 10% to USD 49.78B

MetLife reported FY 2025 net income available to common shareholders of USD 3.17 billion and adjusted earnings available to common shareholders of USD 5.94 billion. Total revenues were USD 77.08 billion, including premiums of USD 49.78 billion and net investment income of USD 22.56 billion. Net investment losses were USD 1.15 billion and net derivative losses were USD 1.94 billion, while market risk benefit remeasurement resulted in gains of USD 0.51 billion. MetLife said it completed a strategic reorganization in Q4 2025, leaving it with six segments (Group Benefits, RIS, Asia, Latin America, EMEA and MIM), plus Corporate & Other. The company returned about USD 4.40 billion to shareholders in 2025 and ended the year with USD 3.60 billion of holding company cash and liquid assets, within its USD 3.00 billion to USD 4.00 billion target. MetLife also reiterated an expectation to generate about USD 25.00 billion of free cash flow over 2025-2029 and said it expects to maintain its holding company cash target in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metlife Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001099219-26-000013), on February 19, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10